FindTrial
Sign In

The effect of neonatal hyperbilirubinemia exchange transfusion therapy: a retrospective study based on medical records.

The effect of neonatal hyperbilirubinemia exchange transfusion therapy: a retrospective study based on medical records.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026623
Enrollment
Unknown
Registered
2019-10-16
Start date
2019-11-11
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hyperbilirubinemia

Interventions

exchange transfusion group + non- exchange transfusion group:N/A

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We reviewed the records of neonates who received exchange transfusion for hyperbilirubinemia at Childrens Hospital of Chongqing Medical University from January 1, 2015 to August 2018, and neonates who achieved exchange transfusion criteria and did not implement the therapy.

Exclusion criteria

Exclusion criteria: Lack of complete medical records.

Design outcomes

Primary

MeasureTime frame
NBNA's score;incidence of acute bilirubin encephalopathy;—

Countries

China

Contacts

Public ContactHu Yuan

Children's Hospital of Chongqing Medical university

547234283@qq.com+86 18723828279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026